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Ion Channels in Epilepsy: 
Blasting Fuse for Neuronal 
Hyperexcitability
Shuzhang Zhang, Yudan Zhu, Jiwei Cheng and Jie Tao
Abstract
Voltage-gated ion channels (VGICs), extensively distributed in the central 
nervous system (CNS), are responsible for the generation as well as modulation 
of neuroexcitability and considered as vital players in the pathogenesis of human 
epilepsy, with regulating the shape and duration of action potentials (APs). For 
instance, genetic alterations or abnormal expression of voltage-gated sodium 
channels (VGSCs), Kv channels, and voltage-gated calcium channels (VGCCs) are 
proved to be associated with epileptogenesis. This chapter aims to highlight recent 
discoveries on the mutations in VGIC genes and dysfunction of VGICs in epilepsy, 
especially focusing on the pathophysiological and pharmacological properties. 
Understanding the role of epilepsy-associated VGICs might not only contribute to 
clarify the mechanism of epileptogenesis and genetic modifiers but also provide 
potential targets for the precise treatment of epilepsy.
Keywords: ion channels, VGSCs, Kv channels, Cav channels, TRPs, mutation, 
epilepsy
1. Introduction
Epilepsy is one of the chronic brain disorders characterized by recurrent seizures 
due to abnormal excessive electrical discharges of cerebral neurons [1]. It is believed 
that genetic factors play a crucial role in the etiopathogenesis of epilepsy. So far 
~1000 genes have been proved to be associated with epilepsy, among which genes 
encoding VGIC predominate [2].
VGICs are pore-forming membrane proteins. Their functions include estab-
lishing APs and maintaining homeostasis by gating the ionic flow traversing the 
cell membrane, managing the ionic flow across cells and regulating Ca2+ signal 
transduction, which are essential to the neuroexcitability, so VGICs are potentially 
involved in epileptogenesis [2]. The association of VGIC genes and epilepsy might 
provide insights into the etiopathogenesis underlying epilepsy. Pathophysiological 
studies illuminated that two key defects are (i) a neuronal disinhibition induced 
by loss-of-function of VGIC gene expressed specifically in inhibitory interneurons 
(for example, Nav1.1 and P/Q VGCCs) or (ii) dysfunction of axon initial segments, 
the neuronal structure in which APs are generated and many VGICs (such as Nav1.2 
and Kv7) are mainly localized (Figure 1). Moreover, clinically originated studies 
identified novel genes, defined their neuronal functions, and sometimes established 
novel physiological principles [2].
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In this chapter, we summarize the epilepsy-associated VGIC genes, the muta-
tions, corresponding phenotypes, and functional changes, aiming to provide clues 
for evaluating the relationship between VGIC genes and epileptogenesis.
2. Voltage-gated sodium channels
VGSCs play a critical role in the generation and propagation of APs in neurons, 
genetic alterations in VGSC genes are considered to be associated with epileptogen-
esis. Mammalian VGSC is composed of a large pseudotetrameric pore-forming α 
subunit with a molecular weight of 260 KDa, and one or more auxiliary β subunits 
(30–40 KDa) [3–5] (Figure 2). Nine subtypes of VGSC α subunits have been found 
in humans, including Nav1.1-Nav1.9, encoded by the genes SCN1A-SCN5A, SCN8A-
SCN11A, respectively.
2.1 Nav1.1
Nav1.1 is mainly distributed in the inhibitory GABAergic neurons of cerebel-
lum and hippocampus. The Nav1.1 gene SCN1A is the clinically most relevant SCN 
gene for epilepsy. More than 1200 mutants have been identified to be associated 
with epilepsy; most of them are febrile seizures [6]. M145T mutation, a well-
conserved amino acid in the first transmembrane segment of domain I of the 
Figure 1. 
Neuronal localization of some relevant voltage-gated ion channels. A schematic view of an excitatory 
pyramidal (orange), an inhibitory (green) neuron, and their synaptic connections is shown. Distinctive 
intracellular compartments are targeted by different populations of VGICs. Examples of which as mentioned 
in this chapter are shown here: in the somatodendritic compartment, Nav, Cav (L- and T-type), TRP, BK, 
and Kv channels; at axon initial segments (AIS) and nodes of Ranvier in pyramidal neurons, Nav1.2, Kv7 
channels; at AIS of inhibitory neurons, Nav1.1; in the somatodendritic compartment of inhibitory neurons, 
BK and Nav1.6; in the presynaptic terminals, Cav P/Q type. GOF represents the gain-of-function mutation of 
VGICs-induced human epilepsy. LOF represents the loss-of-function mutation of VGICs.
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Nav1.1 α-subunit, caused a reduction in peak sodium currents and a positive shift 
in the voltage dependence of activation [7], which provided the first evidence 
that the mild loss-of-function mutations in Nav1.1 may cause a significant portion 
of febrile seizures. Complete loss-of-function mutations in Nav1.1 cause severe 
myoclonic epilepsy of infancy (SMEI or Dravet’s syndrome), which includes severe, 
intractable epilepsy and comorbidities of ataxia and cognitive impairment. Besides, 
homozygous null Nav1.1−/− mice developed ataxia and died on half a month of 
postnatal and did not change the voltage-dependent activity of VGSCs in hip-
pocampal neurons. However, heterozygous Nav1.1+/− mice exhibited spontaneous 
seizures and sporadic deaths after 3 weeks, and the sodium current density was 
substantially reduced in inhibitory interneurons, except in excitatory pyramidal 
neurons [8]. So loss-of-function mutations in Nav1.1 can severely impair sodium 
currents and AP firing in hippocampal GABAergic inhibitory neurons. The func-
tional downregulation in inhibitory neurons might cause the hyperexcitability of 
dentate granule or pyramidal neurons, which could lead to epilepsy in patients with 
SMEI. Experiments in mice have demonstrated that haploinsufficiency of Nav1.1 
channels is sufficient to allow induction of seizures by elevated body temperature, 
supporting that haploinsufficiency of SCN1A is pathogenic in human SMEI which 
has striking temperature and age dependence of onset and progression of epilepsy 
[9]. What is more, SCN1A mutations were mostly missense mutations in GEFS+ 
patients, which are typically well controlled by treatment with antiepileptic drugs 
and no cognitive impairment is observed. The R1648H channels showed the 
reduced function in both excitatory and inhibitory neurons although the biophysi-
cal mechanisms were different, reducing peak sodium currents and enhancing slow 
inactivation in inhibitory neurons versus negatively shifted voltage dependence of 
fast inactivation in excitatory neurons [10]. The similar conclusion had been drawn 
when the R1648H mutation has been inserted into the mouse genome under the 
native promoter [11]. In light of these results, GEFS+ and SMEI may be caused by a 
continuum of mutational effects that selectively impair firing of GABAergic inhibi-
tory neurons, which lead to increase in the excitability of the neural network [12].
Figure 2. 
Structure of voltage-gated sodium channels. Schematic representation of VGSC subunits. The α subunit of the 
VGSC is illustrated together with β1 and β2 subunits; extracellular domains of the β subunits are shown as 
immunoglobulin-like folds, interacting with the loops in α subunits. Roman numerals indicate the domains of 
the α subunit; segments 5 and 6 (shown in green) are the pore-lining segments, and S4 helices (red) make up 
the voltage sensors. The red circle in the intracellular loop of domains III and IV indicates the inactivation gate 
IFM motif; Ψ, probable N-linked glycosylation site. The circles in reentrant loops in each domain represent the 
residues that form the ion selectivity filter.
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2.2 Nav1.2
The mutation of the Nav1.2 gene SCN2A is associated with various epilepsies, such 
as benign familial neonatal seizures (BFNIS), hereditary epilepsy with febrile seizures 
plus (GEFS+), Dravet’s syndrome (DS), and other stubborn childhood epilepsy 
encephalopathy. Nav1.2 subunit is mainly distributed in the axon-initiating segment 
(AIS) and node of Ranvier. SCN2A mutations cause changes in VGSC function and 
expression and result in abnormal neuronal discharge. Because Nav1.2 plays an impor-
tant role in the AIS area during the development, it is more common for infants to 
show SCN2A mutant-induced epilepsy encephalopathy [13]. BFNIS is the most com-
mon phenotype caused by gain-of-function missense mutations in SCN2A [14]. Up to 
now, at least 10 SCN2A mutations associated with BFNIS have been identified. SCN2A 
mutations are also found to result in the reduced expression of Nav1.2 on the surface 
of neurons [15]. Therefore, SCN2A mutants will lead to the decrease of sodium cur-
rent density at node of Ranvier and AIS, seriously affecting the excitability of neurons 
[16]. For missense mutation of SCN2A, p.Tyr1589Cys causes a depolarizing shift of 
steady-state inactivation, increased persistent Na+ current, a slowing of fast inactiva-
tion, and an acceleration of its recovery, which contribute to neuronal hyperexcit-
ability and familial epilepsy [17]. Due to the SCN2A mutation, early infantile epileptic 
encephalopathy (EIEE) patients with burst suppression and tonic-clonic migrating 
partial seizures showed a specific dose-dependent efficacy of VGSC blockers [18]. It 
is mainly caused by the dysfunction of VGSC [19]. By replacing neonatal Nav1.2 with 
adult Nav1.2 in mice, it has been suggested that neonatal Nav1.2 reduced neuronal 
excitability and had a significant impact on seizure susceptibility and behavior.
2.3 Nav1.3
The SCN3A gene, clustered on human chromosome 2q24, encodes the Nav1.3 
subtype [20], which is usually located in the soma of neurons. It is important in the 
integration of synaptic signals, determination of the depolarization threshold, and 
AP transmission [21]. In contrast to the rodent gene which is transiently expressed 
during development, human SCN3A is widely expressed in adult brain [22]. The 
first epilepsy-associated mutation (K354Q ) in SCN3A was found in 2008. K354Q 
mutation decreased inactivation rate and increased INaP [23]. The mutation is not 
sensitive to antiepilepsy drug carbamazepine or oxcarbazepine. K354Q mutation 
causes neuronal abnormal spontaneous discharge and membrane potential parox-
ysmal depolarization [24]. In 2014, four more missense variants were identified in 
SCN3A, which are R357Q, D766N, E1111K, and M1323V [25]. Compared to wild-
type channels, R357Q caused smaller currents, slower activation, and depolarized 
voltage dependences of activation and inactivation. The E1111K mutation evoked 
a significantly greater level of persistent sodium current. All four mutants increase 
current activation in response to depolarizing voltage ramps. These findings support 
for a contribution of Nav 1.3 to childhood epilepsy. Recently, a novel SCN3A variant 
(L247P) was identified by whole exome sequencing of a child with focal epilepsy, 
developmental delay, and autonomic nervous system dysfunction. Voltage clamp 
analysis showed no detectable sodium currents in a heterologous expression system. 
To further test the possible clinical consequences of reduced SCN3A activity, they 
investigated the effect of a hypomorphic Scn3a allele (Scn3a Hyp) on seizure sus-
ceptibility and behavior using a gene trap mouse line. Heterozygous SCN3A mutant 
mice (SCN3A+/Hyp) neither exhibit spontaneous seizures nor hyperthermia-induced 
seizures, but they displayed increased susceptibility to electroconvulsive- and 
chemiconvulsive-induced seizures, which provide evidence that loss-of-function of 
SCN3A may contribute to increased seizure susceptibility [26].
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2.4 Nav1.6
Nav1.6, mainly distributed to the soma and synaptic origin, is important for APs 
generation and propagation [27]. In the development process, Nav1.2 is gradually 
replaced by Nav1.6 in the mature node of Ranvier [28]. The first heterozygous 
missense mutation (p.Asn1768Asp) in the Nav1.6 gene SCN8A was identified 
in 2012 by whole-genome sequencing (WGS) in a patient with severe epileptic 
encephalopathy who exhibited early-onset seizures, autistic features, intellectual 
disability, ataxia, and sudden unexpected death in epilepsy (SUDEP) [29]. Since 
this initial discovery, more than 100 pathogenic SCN8A variants have been identi-
fied in patients with epilepsy [30]. Most of the SCN8A variants have been detected 
in individuals with EIEE.
Different mutations in the SCN8A gene encoding Nav1.6 have differ-
ent effects on epilepsy. For the missense mutation V929F, an evolutionarily 
conserved residue in the pore loop of domain II of Nav1.6, it was found that 
heterozygous mutations produced well-defined spike-wave discharges and are 
associated to absence epilepsy in mice [31]. However, missense mutations in 
Scn8amed−jo were able to improve the epilepsy symptoms of SCN1A+/− hetero-
zygotes. The mechanism might be the decrease in Nav1.6 expression of excit-
atory neurons compensating for the loss of Nav1.1 in inhibitory neurons [32]. 
Recently, more and more de novo and inherited SCN8A epilepsy mutations were 
detected by gene panel analysis [33]. For example, loss-of-function mutants 
[34], underlying the complex seizure phenotype, were identified using specific 
mouse line. It was suggested that decreasing Scn8a expression in cortical excit-
atory neurons could reduce seizures. On the contrary, the decreasing expression 
of SCN8A in the thalamic reticular nucleus (RT) leads to absence seizures. Loss 
of Scn8a will impair tonic firing mode behavior and impair desynchronizing 
recurrent RT-RT synaptic inhibition in the thalamic reticular nucleus, which 
suggested that Scn8a-mediated hypofunction in cortical circuits, conferring 
convulsive seizure resistance, while hypofunction in the thalamus is sufficient to 
generate absence seizures.
2.5 Nav1.7
The SCN9A gene encodes the Nav1.7 subtype, which was initially identified 
in the peripheral nervous system, sympathetic ganglion, and olfactory sensory 
neurons [35–38]. Nav1.7 is also found expressed in the central nervous system such 
as in the cerebral cortex and hippocampus [39]. A missense mutation of SCN9A 
(N641Y), at a conserved amino acid residue located at the intracellular loop between 
domain I and II, is associated with a family of febrile seizures (FS, N641Y). Mice 
carrying N641Y mutations were more susceptible to electrical stimulation-induced 
clonic and tonic seizures [40]. However, it is still unclear how SCN9A gene mutation 
caused epilepsy in the CNS.
3. Potassium channels
K+ channels control the resting membrane potential and enable rapid repolariza-
tion of the AP by producing outward K+ currents, thus limiting neuronal excit-
ability. K+ channels are composed of four pore forming a subunits and modulatory 
b subunits. Kv channels are the largest ion channel group (Kv1–Kv12) that are 
expressed substantially in the CNS. Dysfunction of Kv channels including Ca2+-
activated K+ channels, are associated with epilepsy [2].
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3.1 Large conductance calciumactivated potassium channel
Large conductance calcium-activated potassium (BK) channels, consisting of 
functional α subunit and the tissue-specific regulatory subunits (β1–4 and γ1–4), 
are widely distributed in the CNS. BK channels are usually considered as vital play-
ers in the development of epilepsy (Figure 3), with the evidence including the K+ 
derangement and regulating AP shape and duration [41, 42].
Gain-of-function mutation of BK, promoting the high-frequency neuron firing, 
is associated with spontaneous epileptic seizures paradoxically in both humans and 
rodents [43]. In fact, patients suffering from generalized epilepsy were detected a 
site mutation D434G at the RCK1 domain of BK α subunit. D434G increased the 
opening time of BK, through the enhancement of Ca2+ sensitivity [43]. In terms of 
functionality, the enhanced membrane excitability is associated with the increased 
BK activity and fAHP consequent [43, 44]. The augment seems to be induced by 
an increased recovery rate, underlying fast currents of VGSCs with a APs’ reduced 
refractory period and/or through disinhibiting thalamocortical circuits by blocking 
brain GABAergic interneurons [43, 45, 46].
The knockout mice of BK channel β4 subunit exhibit temporal lobe epilepsy 
(TLE) seizure associated with a gain-of-function phenotype of BK, which not only 
sharpens APs but also induces a higher neuronal firing frequency in hippocampus 
DG granule cells [47].It is worth mentioned that epileptic seizures themselves also 
could induce a gain-of-function effect to BK. Picrotoxin and pentylenetetrazol 
(PTZ) caused generalized tonic-clonic epileptic seizures, with giving rise to a gain-
of-function effect on BK channels, presenting increased BK currents and neuron 
firing in the neocortex [48]. It is of interest that BK-specific inhibitors attenuated 
generalized tonic-clonic epileptic seizures in picrotoxin or PTZ-induced epilepsy 
models, which suppressed the increase of neuron firing [48, 49].
Figure 3. 
Yin and Yang of BK channels in epilepsy. For epilepsy suppression, BK (α) channels act as negative feedback 
regulators on calcium rise and transmitter release in most synapses. Activation of mitoBK channel subtypes 
(α or α+β4) may contribute to suppressing seizure as well as conferring neuroprotection via the inhibition of 
ROS synthesis [54]. For epilepsy promotion, astrocyte and OPCs BK channel subtypes (α+β1 or α+β4) may 
induce elevate [K+]o, causing membrane depolarization as well as neuronal hyperexcitation. Microglial BK 
channels (α+β3) may involve in the neuroinflammation during status epilepsy. Mutation D434G of α causes 
the neurohyperexcitation in hereditary epilepsy. However, ubiquitin ligase CRL4ACRBN could inhibit the 
overactivation of BK channels.
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Loss-of-function phenotype of BK might also contribute to the pathological 
process of clinical TLE. It was reported that two siblings suffered from the severe 
cerebellar atrophy and developmental delay, who adopted the exome analysis that 
identified a homozygous frameshift duplication in BK gene KCNMA1 (c.2026dupT; 
p.(Tyr676 Leufs*7)) in children from a consanguineous family with epilepsy [50].
KCNMB3, encoding the auxiliary BK β3, mapping the human chromosome 3 
(3q26.3-q27) [51], is duplicated in the dup (3q) syndrome, which is characterized by 
neurological abnormalities, especially epileptic seizures [51]. Because of the dup (3q) 
syndrome having early onset during developmental process, the KCNMB3 duplication 
implies that β3 subunits overexpression might contribute to the etiology of epilepsy. 
Similarly, site mutations might also contribute to both neurohyperexcitation by a single 
nucleotide deletion at KCNMB3 exon 4 (delA750), which is associated with the gener-
alized epilepsy, especially in the form of the typical absence epilepsy [52]. BK coex-
pressed with β3 variant of β3b-V4 (delA750) shows fast inactivation properties [53], 
which suggest that BK currents were reduced and the repolarization of cell membrane 
was attenuated during an action potential, eventually leading to neurohyperexcitation.
3.2 Voltage-gated potassium channel subfamily KQT (KCNQ )
Kv7 is its seventh member of Kv channel family (Kv1–Kv12). The Kv7.1 mutation 
mediates type 1 long QT syndrome (long-QT syndrome type 1, LQT1) and is there-
fore named KCNQ1 (K, potassium; CN, channel; Q, LQT). KCNQ has five subtypes 
of KCNQ1–KCNQ5, which play crucial roles in physiological functions. Dysfunction 
of KCNQ is associated with many diseases.
KCNQ1 is mainly distributed in the heart, which mediates cardiac delayed- 
rectifier K+ current and maintains the normal repolarization process of cardiomyo-
cytes [55]. KCNQ2–KCNQ5 are mainly distributed in central and peripheral neuronal 
tissues, of which KCNQ2 and KCNQ3 are distributed in brain regions [56]. KCNQ2 
and KCNQ3 form functional heterotetramers, which are the main molecular bases 
for the formation of M currents that can be inhibited by acetylcholine M1 receptor 
activation [57]. Abundant KCNQ2 and KCNQ3 mutations could induce abnormal M 
currents, causing similarities in neonatal seizures and other nervous system diseases.
Benign familial neonatal seizure (BFNS) is an autosomal dominant idiopathic 
epilepsy syndrome that occurs on the 2nd to 8th day after birth and stops spontane-
ously after a few weeks. Whereas 15% of patients in later life may have recurrence 
of epilepsy [58]. With the study of pathogenic genes in epilepsy, 60–70% of patients 
with BFNS were found to be associated with KCNQ2 and KCNQ3 mutations. More 
than 80 different mutations have been reported on KCNQ2, and multiple mutations 
on KCNQ3 are associated with BFNS. Soldovieri et al. [58] studied the genes of 17 
BFNS clinical patients. Sixteen different heterozygous mutations were found in 
KCNQ2, including 10 substitutions, 3 insertions/deletions, and 3 large deletions. One 
substitution was found in KCNQ3. Most of these mutations were novel, except for four 
KCNQ2 substitutions that were shown to be recurrent. Electrophysiological studies 
in mammalian cells revealed that homomeric or heteromeric KCNQ2 and/or KCNQ3 
channels carrying mutant subunits with newly found substitutions displayed reduced 
current densities. Borgatti studied a BFNS family with four affected members: two 
of them exhibit BFNS only, while the other two, in addition to BFNS, present either 
with a severe epileptic encephalopathy or with focal seizures and mental retardation. 
All affected members of this family carry a novel missense mutation in the KCNQ2 
gene (K526N), disrupting the tridimensional conformation of a C-terminal region 
of the channel subunit involved in accessory protein binding. When heterologously 
expressed in CHO cells, potassium channels containing mutant subunits in homo-
meric or heteromeric configuration with wild-type KCNQ2 and KCNQ3 subunits 
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exhibit an altered voltage-dependence of activation, without changes in intracellular 
trafficking and plasma membrane expression. The KCNQ2 K526N mutation might 
affect M-channel function by disrupting the complex biochemical signaling involv-
ing KCNQ2 C-terminus [59, 60]. KCNQ2 or KCNQ3 mutations cause M current to be 
downregulated, and the frequency of neuronal firing increases, leading to epilepsy.
3.3 G protein-coupled Kir channel
Inward-rectifier potassium channels (Kir, IRK) are a specific subset of potas-
sium channels. To date, seven subfamilies have been identified, which are associ-
ated with a variety of diseases [61]. The G-protein-coupled Kir (GIRK) channels 
belong to the subfamily of Kir3 (GIRKs) which are activated by ligand-stimulated 
G protein-coupled receptors (GPCRs). GPCRs, interacting with GIRK channels, 
facilitate their activation, resulting in hyperpolarization of the cell membrane [61].
GIRK channels have four identified subunits (GIRK1–4, encoded by KCNJ3, 
KCNJ6, KCNJ9, and KCNJ5, respectively) in mammals, existing in vivo both as 
homotetramers and heterotetramers with unique biophysical properties, regula-
tion, and distribution [61, 62]. GIRK 1, 2, 3, and 4 subunits are expressed in the 
brain, localized in certain axons, postsynaptic, and presynaptic regions [63]. GIRK 
channels may be involved not only in slow inhibitory postsynaptic potentials but 
also in the presynaptic modulation of neuronal activity [61].
GIRK in the CNS is a heterotetramer composed of GIRK1 and GIRK2 subunits 
[63], which is responsible for maintaining the resting membrane potential and 
excitability of the neuron [64]. GIRK1 and GIRK2 subunits are found in the den-
dritic areas of neurons highly [63] correlate with the large concentration of GABAB 
receptors. Once the GABAB receptors are activated by their ligands, they can in turn 
activate IRK, mediating a significant part of the GABA postsynaptic inhibition [63].
Alterations in GIRK function have been associated with pathophysiology of 
severe brain disorders, including epilepsy. In this regard, a GIRK2 knockout mouse 
model resulted to be more susceptible to develop both spontaneous and induced 
seizures in respect to wild-type mice [65]. In particular, mice carrying a p Gly156Ser 
mutation displayed an epileptic phenotype [66]. Indeed, this mutation has been 
found to alter the putative ion-permeable, pore-forming domain of the channel, 
inducing Ca2+ overload in cells and reducing channel availability, leading thus to 
neurodegeneration and seizure susceptibility [67].
An increased expression of GIRK was observed in rat brain after an electrocon-
vulsive shock, probably altering the excitability of granule cells and the functions 
of neurotransmitter receptors which are coupled to these channels [68]. Another 
evidence in support of a role of GIRK in epilepsy was provided by the demonstra-
tion that ML297, a potent and selective activator of GIRK, showed epileptogenic 
properties in mice [69]. On the other hand, the inhibition of GIRK activity by drugs 
causes seizures [70]. All these considerations imply that changes in Kir3 channel 
activity may alter the susceptibility to seizures.
4. Calcium channels
As an important second messenger, Ca2+ plays a vital role in normal brain function 
and in the pathophysiological process of different neurodegenerative diseases. Ca2+ 
entry via VGCCs conveys the electric signals to intracellular transduction cascades 
in a wide variety of cells [71]. VGCCs were first identified by Fatt and Katz [72] and 
shown to consist of several subunits [73, 74]. VGCCs were divided into low-voltage-
activated (LVA) and high-voltage-activated (HVA), based on electrophysiological and 
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pharmacological properties. HVA channels, composed of α1, β, α2δ, γ subunit, are fur-
ther divided into L, N, P, and Q types, which have an activation threshold at membrane 
voltage positive to −20 mV [75]. LVA channels, also called T type, consist only of the α1 
subunit, activated at a membrane voltage positive to −70 mV. It is composed of trans-
membrane topology with four homologous transmembrane domains, each containing 
six transmembrane segments and a pore region between segments S5 and S6.
4.1 L-type Cav
The L-type VGCC family has four members, Cav1.1–1.4, of which α subunits 
present tissue-specific expression, such as the α1D subunit in the brain. The L-type 
VGCC family shapes neuronal firing and activates Ca2+-dependent pathways 
involved in regulation of gene expression [76]. Cav1.2 channels appear to contribute 
critically to the generation of febrile seizures, which was proved by testing the 
excitability of hippocampal pyramidal cells in rat brain slices [77]. The Wistar 
Albino Glaxo/Rij (WAG/Rij) model experiments suggest that L-type calcium 
channels play a positive role in the frequency and duration of epileptic spikes 
[78]. Verapamil, an L-type VGCC blocker, could significantly reduce TLE seizure, 
enhancing the expression of the α subunit of γ-GABAAR [79].
4.2 P/Q-, N-, and R-type Cav
P/Q-, N-, and R-type are corresponding to Cav2.1, Cav2.2, and Cav2.3, respectively, 
which initiate rapid synaptic transmission, regulated primarily by direct interaction 
with G proteins and SNARE (soluble N-ethylmaleimide-sensitive factor attachment 
protein receptor) and secondarily by protein phosphorylation. The loss function of 
P/Q VGCC could lead to epileptic spikes, paroxysmal dystonia and ataxia. If P/Q 
VGCCs were blocked, it could disrupt the triggering synaptic neurotransmitter release 
[80]. Spikes of Cacna1aNtsr−/− mice are increased in layer VI corticothalamic neurons 
compared with control group, suggesting that Cav P/Q deletion generates absence 
epilepsy [81]. Cacna1a LOF from parvalbumin (PV)(+)  
and somatostatin (SST)(+) interneurons results in severe generalized epilepsy. It 
might be the mechanism for severe generalized epilepsy that the loss of Cav2.1 chan-
nel function from cortical PV(+) interneurons inhibits GABA release from these 
cells, which impairs their ability to constrain cortical pyramidal cell excitability 
[82]. When knocking out the cerebellar Cav2.1 channel in mice, cortical function is 
changeable, which caused movement disorders and epilepsy [83]. In two families with 
idiopathic epilepsy, the loss of function mutation in γ4 subunits, auxiliary subunit 
of Cav2.1 channels, could also cause seizures, and maybe aggravate seizures [84]. 
Downregulation of α2δ2 subunits in rats will generate 5–7 Hz epileptic wave accompa-
nied by ataxia [85]. N-type calcium channels are mainly distributed in the nucleus of 
different neurons and glial cells. In the pilocarpine model, Cav2.2 expression decreased 
in the granule layer of the dentate gyrus and the pyramidal cells of the CA3 region 
during the acute phase of seizure. However, the expression of N-type calcium channels 
increased in the subsequent chronic phase, which demonstrated that the increase of 
N-type calcium channels might be associated with recurrent status epilepticus [86]. 
R-type calcium channel, Cav2.3, is mainly distributed in the presynaptic membrane, 
such as hippocampal mossy fibers, globus pallidus, and neuromuscular junctions. 
Knocking out R-type calcium channels could increase the susceptibility of seizures, 
with altering the seizure form [87]. The lack of Cav2.3 resulted in a marked decrease in 
the sensitivity of the animal to γ-butyrolactone-induced absence epilepsy and change 
thalamocortical network oscillations [88]. Administration of kainic acid revealed 
alteration in behavioral seizure architecture, dramatic resistance to limbic seizures 
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and excitotoxic effects in Cav2.3−/− mice compared with controls. It indicated that the 
Cav2.3 plays a crucial role in both hippocampal ictogenesis and seizure generalization 
and is of central importance in neuronal degeneration after excitotoxic events [89].
4.3 T-type Cav
T-type channels, widely distributed in the thalamus, are important for the repeti-
tive firing of APs in rhythmically firing cells, which could be activated and inactivated 
more rapidly at more negative membrane potentials than other VGCCs [90]. Three 
subtypes of T-type channels have been identified, designated as Cav3.1, Cav3.2, and 
Cav3.3; they correspond to complexes containing the pore-forming α1 subunits, α1G, 
α1H, and α1I, respectively [91]. It has long been suggested that generalized absence 
seizures are accompanied by hyperexcitable oscillatory activities in the thalamocorti-
cal network [92]. The evidence that succinimide and related anticonvulsants could 
block thalamic T-type channels make researchers speculate that T-type Ca2+ channels 
might be related to the pathogenesis of spike-and-wave discharges (SWDs) in gen-
eralized absence seizures [93]. In the kainate epilepsy model, Cav3.1−/− mice display 
significantly reduced duration of seizures compared to wild type, but the frequency of 
seizures increased slightly [94]. In the WAG/Rij model, the expression of Cav3.1 may 
be related to age, and blocking Cav3.1 can reduce the onset of epilepsy [94, 95] which 
suggested that decrease in Cav3.1 channel expression and Ca2+ current component that 
they carry in thalamocortical relay neurons serves as a protective measure against early 
onset of SWD and absence seizures [96]. Notably, Cav3.1−/− mice are resistant to SWD 
seizures specifically induced by γ-GABABR agonists. Simultaneously, the γ-GABABR 
agonists induced only very weak and intermittent SWDs in Cav3.1−/− mice [97]. Cav3.2 
single nucleotide mutation has been reported in patients with childhood absence epi-
lepsy and other types of idiopathic generalized epilepsies [98, 99]. Gain-of-function 
mutations (C456S) in Cav3.2 channels increase seizure susceptibility by directly alter-
ing neuronal electrical properties and indirectly by changing gene expression [100].
5. Transient receptor potential channels
Transient receptor potential (TRP) channels, which could induce a transient 
voltage changes to continuous light mutations of Drosophila melanogaster, are 
expressed in photoreceptors carrying trp gene. The first homologous human gene 
was reported in 1995. There are 30 trp genes, and more than 100 TRP channels have 
been identified so far, and TRP channels were divided into 7 subfamilies, including 
TRPC, TRPV, TRPM, TRPA, TRPP, TRPML, and TRPN. Focus on TRPs, one family 
of Ca2+ channels, plays a role in neuronal excitability. It is obviously known that 
Ca2+ is an important second messenger, which is related to the etiology of epilepsy 
[101]. Therefore, TRP channels are thought to be partially responsible for epileptic 
seizures, especially for TPRC and TRPV1 channels.
5.1 Canonical transient receptor potential (TRPC)
TRPC channels are the closet homolog to Drosophila TRP channels. Based on 
the functional comparisons and sequence alignments, four subsets of mammalian 
TRPCs (TRPC1, TRPC2, TRPC3/6/7, and TRPC4/5) have been generated [101]. 
These channels form receptor-modulated currents in the mammalian brain and 
important to SE-induced neuronal cell death. These channels could play a critical 
role in the generation of spontaneous seizures. TRPC1 and TRPC4 are expressed 
in CA1 pyramidal neurons. The amplitude of the plateau and the number of spikes 
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were significantly reduced in mice without TRPC1 and TRPC4 [102]. TRPC3 chan-
nels are found to be responsible for pilocarpine-induced status epilepticus (SE) in 
mice. The reduction on SE in TRPC3 KO mice is caused by a selective attenuation 
of pilocarpine-induced theta wave activity [103]. TRPC7 can be detected in CA3 
pyramidal neurons largely. The spontaneous seizures in CA3 pyramidal neurons 
and the pilocarpine-induced increase in gamma wave activities during the latent 
period could be significantly reduced by ablating the gene TRPC7 [104].
5.2 Transient receptor potential vanilloid 1 (TRPV1)
TRPV1 is one subfamily of TRP channels, expressing in most neurons. The 
expression of TRPV1 protein in epileptic brain areas was increased [105], but 
the epileptic activity in hippocampal slices was decreased by iodoresiniferatoxin 
(IRTX), a selective TRPV1 channel antagonist [106]. It is well known that glutamate 
could be released when the TRPV1 channel was activated [107], and the glutamate 
neurotransmitters are related to the etiology of epilepsy. Thus, focusing the TRPV1 
channels activity may be important for the modulating neuronal excitability in 
epilepsy [106]. Recent studies showed that the high expression of TRPV1 channels 
could induce the temporal lobe epilepsy [105]. Cytosolic calcium elevation through 
activation of TRPV1 channels plays a physiologically relevant role in the regulation 
of epileptic seizures [108], decreasing the calcium accumulation by inhibiting the 
TRPV1 channels, could play a neuronal protective role against epilepsy-induced Ca2+ 
entry in hippocampal neurons. As mentioned above, the TRPV1 could be activated 
by hyperthermia; the hyperthermia-induced TRPV1 might be an effective candidate 
therapeutic target in heat-induced hyperexcitation [109, 110]. The activation of 
TRPV1 promotes glutamate release by increasing the excitability of neurons and 
synaptic terminals [111]. Whereas the activities would be reduced in hippocampus 
slices of rats after given the CPZ and ITRX, which were the TRPV1 channel blockers.
6. Antiepileptic therapy and beyond
At present, the treatment of epilepsy is still dominated by drugs. More than 35% of 
marketed antiepileptic drugs target VGICs, such as phenytoin, carbamazepine, oxcar-
bazepine, and ethosuximide. Phenytoin and carbamazepine are broad-spectrum anti-
epileptic drugs blocking VGSCs as their primary mechanism of action. For example, 
phenytoin is a more effective inhibitor of SCN8A-I1327V than other drugs [112], which 
could be used in treating patients with gain-of-function mutations of SCN8A. Different 
types of VGCCs play different roles in the pathological process of epilepsy. Decreased 
expression of P/Q type could induce epilepsy, whereas increased expression of N-type 
and T-type calcium channels could lead to epilepsy. Calcium blockers including 
ethosuximide have been widely accepted for the treatment of absence epilepsy [71]. 
Gain-of-function BK channels contribute to epileptogenesis and seizure generation. 
BK-blocking agents, like paxilline [49], might be used as potential therapeutic drugs.
In the future, novel techniques might contribute to develop reasonable therapies for 
treating inherited or acquired epileptic syndromes. For instance, induced pluripotent 
stem cells (IPS) and genetically engineering animal models could be used for accurate 
treatments of epilepsy. Single-nucleotide polymorphisms (SNPs) of VGIC genes from 
hereditary epilepsy patients could be detected by de novo genomic sequencing. VGICs 
of IPS cells could be mutated by CRISPR-Cas9 according to the information of these 
SNPs [113]. Through inducing IPS cells differentiated into neurons, phenotype of VGIC 
gene SNPs could be well investigated. It is also a well-detection platform for selecting 
antiepileptic drugs that would be sensitive to mutated VGICs in vitro [112]. For in vivo 
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tests, besides transgenic mice, construction of nematode or zebrafish epileptic models 
may be creating a shortcut for choosing suitable and personalized antiepileptic drugs 
[114, 115]. In addition to drug control, optogenetics and ultrasonic control are hopeful 
to suppress the epileptic seizures induced by VGIC dysfunction [116, 117].
7. Conclusion
We systemically summarized the mutations and phenotype information of 21 
epilepsy-associated VGIC genes. The dysfunctional VGICs are like the blasting fuse 
for neuronal hyperexcitability. We have good reason to believe that epilepsy-associ-
ated mutations of VGICs could be considered as a biomarker, which is possible to be 
one of the molecular bases underlying the classification of epilepsy syndromes iden-
tified by modern medicine. VGICs are the important targets for many antiepileptic 
drugs. Novel VGIC modulators are potentially effective strategy for the development 
of novel antiepileptic drugs. Individualized precise treatment using matching VGIC 
drugs will provide novel research directions and antiepileptic strategies.
Acknowledgements
This work was supported by National Science Foundation of China (Nos. 
81603410 and 31771191), Innovation Fund of Putuo District Health System (No. 
17-PT-10), Shanghai Municipal Commission of Health and Family Planning Fund 
(Nos. 20184Y0086, 2016JP007, and 2018JQ003), Project within budget of Shanghai 
University of Traditional Chinese Medicine (No. 18TS086), the Key Speciality 
Program (No. 2016102A) and Research Project (No. 2016208A) of Putuo Hospital, 
Shanghai University of Traditional Chinese Medicine.
Conflict of interest
The authors confirm that this article content has no conflict of interest.
Author details
Shuzhang Zhang1,2, Yudan Zhu1, Jiwei Cheng1 and Jie Tao1*
1 Department of Central Laboratory and Neurology, Putuo Hospital, Shanghai 
University of Traditional Chinese Medicine, Shanghai, China
2 Laboratory of Neuropharmacology and Neurotoxicology, Shanghai University, 
Shanghai, China
*Address all correspondence to: jietao_putuo@foxmail.com
13
Ion Channels in Epilepsy: Blasting Fuse for Neuronal Hyperexcitability
DOI: http://dx.doi.org/10.5772/intechopen.83698
[1] Chang BS, Lowenstein DH. Epilepsy. 
The New England Journal of Medicine. 
2003;349(13):1257-1266. DOI: 10.1056/
NEJMra022308
[2] Wei F, Yan LM, Su T, et al. Ion 
channel genes and epilepsy: Functional 
alteration, pathogenic potential, and 
mechanism of epilepsy. Neuroscience 
Bulletin. 2017;33(4):455-477. DOI: 
10.1007/s12264-017-0134-1
[3] Catterall WA. From ionic currents to 
molecular mechanisms: The structure 
and function of voltage-gated sodium 
channels. Neuron. 2000;26(1):13-25. 
DOI: 10.1016/S0896-6273(00)81133-2
[4] Fozzard HA, Hanck DA. Structure 
and function of voltage-dependent 
sodium channels: Comparison of brain 
II and cardiac isoforms. Physiological 
Reviews. 1996;76(3):887-926. DOI: 
10.1152/physrev.1996.76.3.887
[5] Goldin AL, Barchi RL, Caldwell JH,  
et al. Nomenclature of voltage-
gated sodium channels. Neuron. 
2000;28(2):365-368. DOI: 10.1016/
S0896-6273(00)00116-1
[6] Meng H, Xu HQ , Yu L, et al. 
The SCN1A mutation database: 
Updating information and analysis 
of the relationships among genotype, 
functional alteration, and phenotype. 
Human Mutation. 2015;36(6):573-580. 
DOI: 10.1002/humu.22782
[7] Mantegazza M, Gambardella A, 
Rusconi R, et al. Identification of 
an Nav1.1 sodium channel (SCN1A) 
loss-of-function mutation associated 
with familial simple febrile seizures. 
Proceedings of the National Academy 
of Sciences of the United States of 
America. 2005;102(50):18177-18182. 
DOI: 10.1073/pnas.0506818102
[8] Yu FH, Mantegazza M, Westenbroek 
RE, et al. Reduced sodium current in 
GABAergic interneurons in a mouse 
model of severe myoclonic epilepsy 
in infancy. Nature Neuroscience. 
2006;9(9):1142-1149. DOI: 10.1038/
nn1754
[9] Oakley JC, Kalume F, Yu FH, et al. 
Temperature- and age-dependent 
seizures in a mouse model of severe 
myoclonic epilepsy in infancy. 
Proceedings of the National Academy 
of Sciences of the United States of 
America. 2009;106(10):3994-3999. 
DOI: 10.1073/pnas.0813330106
[10] Tang B, Dutt K, Papale L, et al. A 
BAC transgenic mouse model reveals 
neuron subtype-specific effects of 
a generalized epilepsy with febrile 
seizures plus (GEFS+) mutation. 
Neurobiology of Disease. 2009;35(1): 
91-102. DOI: 10.1016/j.nbd.2009.04.007
[11] Martin MS, Dutt K, Papale LA, et al. 
Altered function of the SCN1A voltage-
gated sodium channel leads to gamma-
aminobutyric acid-ergic (GABAergic) 
interneuron abnormalities. The 
Journal of Biological Chemistry. 
2010;285(13):9823-9834. DOI: 10.1074/
jbc.M109.078568
[12] Catterall WA, Kalume F, Oakley JC.  
NaV1.1 channels and epilepsy. The 
Journal of Physiology. 2010;588(Pt 11): 
1849-1859. DOI: 10.1113/jphysiol. 
2010.187484
[13] Liao Y, Deprez L, Maljevic S, et al. 
Molecular correlates of age-dependent 
seizures in an inherited neonatal-infantile 
epilepsy. Brain. 2010;133(Pt 5): 
1403-1414. DOI: 10.1093/brain/awq057
[14] Heron SE, Crossland KM, 
Andermann E, et al. Sodium-
channel defects in benign familial 
neonatal-infantile seizures. Lancet. 
2002;360(9336):851-852. DOI: 10.1016/
s0140-6736(02)09968-3
References
Epilepsy - Advances in Diagnosis and Therapy
14
[15] Misra SN, Kahlig KM, George AL Jr. 
Impaired NaV1.2 function and reduced 
cell surface expression in benign 
familial neonatal-infantile seizures. 
Epilepsia. 2008;49(9):1535-1545. DOI: 
10.1111/j.1528-1167.2008.01619.x
[16] Boiko T, Van Wart A, Caldwell JH,  
et al. Functional specialization of 
the axon initial segment by isoform-
specific sodium channel targeting. 
The Journal of Neuroscience. 
2003;23(6):2306-2313. DOI: 10.1523/
JNEUROSCI.23-06-02306.2003
[17] Lauxmann S, Boutry-Kryza N, 
Rivier C, et al. An SCN2A mutation 
in a family with infantile seizures 
from Madagascar reveals an increased 
subthreshold Na(+) current. Epilepsia. 
2013;54(9):e117-e121. DOI: 10.1111/
epi.12241
[18] Dilena R, Striano P, Gennaro E, 
et al. Efficacy of sodium channel 
blockers in SCN2A early infantile 
epileptic encephalopathy. Brain & 
Development. 2017;39(4):345-348. DOI: 
10.1016/j.braindev.2016.10.015
[19] Gazina EV, Leaw BT, Richards KL,  
et al. ‘Neonatal’ Nav1.2 reduces 
neuronal excitability and affects seizure 
susceptibility and behaviour. Human 
Molecular Genetics. 2015;24(5): 
1457-1468. DOI: 10.1093/hmg/ddu562
[20] Catterall WA, Goldin AL, Waxman 
SG. International Union of Pharmacology. 
XLVII. Nomenclature and structure-
function relationships of voltage-gated 
sodium channels. Pharmacological 
Reviews. 2005;57(4):397-409. DOI: 
10.1124/pr.57.4.4
[21] Yu FH, Catterall WA. Overview 
of the voltage-gated sodium channel 
family. Genome Biology. 2003;4(3):207. 
DOI: 10.1186/gb-2003-4-3-207
[22] Whitaker WR, Faull RL, Waldvogel 
HJ, et al. Comparative distribution 
of voltage-gated sodium channel 
proteins in human brain. Brain 
Research. Molecular Brain Research. 
2001;88(1-2):37-53. DOI: 10.1016/
s0169-328x(00)00289-8
[23] Holland KD, Kearney JA, Glauser 
TA, et al. Mutation of sodium channel 
SCN3A in a patient with cryptogenic 
pediatric partial epilepsy. Neuroscience 
Letters. 2008;433(1):65-70. DOI: 
10.1016/j.neulet.2007.12.064
[24] Estacion M, Gasser A, Dib-Hajj SD,  
et al. A sodium channel mutation 
linked to epilepsy increases ramp and 
persistent current of Nav1.3 and induces 
hyperexcitability in hippocampal 
neurons. Experimental Neurology. 
2010;224(2):362-368. DOI: 10.1016/j.
expneurol.2010.04.012
[25] Vanoye CG, Gurnett CA, Holland 
KD, et al. Novel SCN3A variants 
associated with focal epilepsy in 
children. Neurobiology of Disease. 
2014;62:313-322. DOI: 10.1016/j.
nbd.2013.10.015
[26] Lamar T, Vanoye CG, Calhoun J,  
et al. SCN3A deficiency associated 
with increased seizure susceptibility. 
Neurobiology of Disease. 2017;102: 
38-48. DOI: 10.1016/j.nbd.2017.02.006
[27] Blumenfeld H, Lampert A,  
Klein JP, et al. Role of hippocampal 
sodium channel Nav1.6 in 
kindling epileptogenesis. 
Epilepsia. 2009;50(1):44-55. DOI: 
10.1111/j.1528-1167.2008.01710.x
[28] Boiko T, Rasband MN, Levinson SR, 
et al. Compact myelin dictates the 
differential targeting of two sodium 
channel isoforms in the same axon. 
Neuron. 2001;30(1):91-104. DOI: 
10.1016/s0896-6273(01)00265-3
[29] Veeramah KR, O'Brien JE, Meisler 
MH, et al. De novo pathogenic SCN8A 
mutation identified by whole-genome 
sequencing of a family quartet affected 
by infantile epileptic encephalopathy 
15
Ion Channels in Epilepsy: Blasting Fuse for Neuronal Hyperexcitability
DOI: http://dx.doi.org/10.5772/intechopen.83698
and SUDEP. American Journal of 
Human Genetics. 2012;90(3):502-510. 
DOI: 10.1016/j.ajhg.2012.01.006
[30] Meisler MH, Helman G, Hammer 
MF, et al. SCN8A encephalopathy: 
Research progress and prospects. 
Epilepsia. 2016;57(7):1027-1035. DOI: 
10.1111/epi.13422
[31] Papale LA, Beyer B, Jones JM, et al. 
Heterozygous mutations of the voltage-
gated sodium channel SCN8A are 
associated with spike-wave discharges 
and absence epilepsy in mice. Human 
Molecular Genetics. 2009;18(9):1633-1641. 
DOI: 10.1093/hmg/ddp081
[32] Martin MS, Tang B, Papale LA, 
et al. The voltage-gated sodium channel 
Scn8a is a genetic modifier of severe 
myoclonic epilepsy of infancy. Human 
Molecular Genetics. 2007;16(23):2892-2899. 
DOI: 10.1093/hmg/ddm248
[33] Butler KM, da Silva C, Shafir Y, 
et al. De novo and inherited SCN8A 
epilepsy mutations detected by gene 
panel analysis. Epilepsy Research. 
2017;129:17-25. DOI: 10.1016/j.
eplepsyres.2016.11.002
[34] Makinson CD, Tanaka BS, Sorokin 
JM, et al. Regulation of thalamic and 
cortical network synchrony by Scn8a. 
Neuron. 2017;93(5):1165-1179. e6. DOI: 
10.1016/j.neuron.2017.01.031
[35] Toledo-Aral JJ, Moss BL, He ZJ, et al. 
Identification of PN1, a predominant 
voltage-dependent sodium channel 
expressed principally in peripheral 
neurons. Proceedings of the National 
Academy of Sciences of the United 
States of America. 1997;94(4):1527-1532. 
DOI: 10.1073/pnas.94.4.1527
[36] Rush AM, Dib-Hajj SD, Liu S, et al. 
A single sodium channel mutation 
produces hyper- or hypoexcitability in 
different types of neurons. Proceedings 
of the National Academy of Sciences 
of the United States of America. 
2006;103(21):8245-8250. DOI: 10.1073/
pnas.0602813103
[37] Ahn HS, Black JA, Zhao P, et al. 
Nav1.7 is the predominant sodium 
channel in rodent olfactory sensory 
neurons. Molecular Pain. 2011;7:32. 
DOI: 10.1186/1744-8069-7-32
[38] Weiss J, Pyrski M, Jacobi E, et al. 
Loss-of-function mutations in sodium 
channel Nav1.7 cause anosmia. Nature. 
2011;472(7342):186-190. DOI: 10.1038/
nature09975
[39] Mechaly I, Scamps F, Chabbert C, 
et al. Molecular diversity of voltage-
gated sodium channel alpha subunits 
expressed in neuronal and non-
neuronal excitable cells. Neuroscience. 
2005;130(2):389-396. DOI: 10.1016/j.
neuroscience.2004.09.034
[40] Singh NA, Pappas C, Dahle EJ, et al. 
A role of SCN9A in human epilepsies, 
as a cause of febrile seizures and as a 
potential modifier of Dravet syndrome. 
PLoS Genetics. 2009;5(9):e1000649. 
DOI: 10.1371/journal.pgen.1000649
[41] Latorre R, Castillo K, Carrasquel-
Ursulaez W, et al. Molecular 
determinants of BK channel functional 
diversity and functioning. Physiological 
Reviews. 2017;97(1):39-87. DOI: 
10.1152/physrev.00001.2016
[42] Tao J, Lan Z, Wang Y, et al. 
Large-conductance calcium-activated 
potassium channels in glomerulus: 
From cell signal integration to disease. 
Frontiers in Physiology. 2016;7:248. 
DOI: 10.3389/fphys.2016.00248
[43] Du W, Bautista JF, Yang H, 
et al. Calcium-sensitive potassium 
channelopathy in human epilepsy and 
paroxysmal movement disorder. Nature 
Genetics. 2005;37(7):733-738. DOI: 
10.1038/ng1585
[44] Yang J, Krishnamoorthy G, 
Saxena A, et al. An epilepsy/
Epilepsy - Advances in Diagnosis and Therapy
16
dyskinesia-associated mutation 
enhances BK channel activation by 
potentiating Ca2+ sensing. Neuron. 
2010;66(6):871-883. DOI: 10.1016/j.
neuron.2010.05.009
[45] Gu N, Vervaeke K, Storm JF.  
BK potassium channels facilitate 
high-frequency firing and cause 
early spike frequency adaptation 
in rat CA1 hippocampal pyramidal 
cells. The Journal of Physiology. 
2007;580(Pt. 3):859-882. DOI: 10.1113/
jphysiol.2006.126367
[46] Martire M, Barrese V, D'Amico M,  
et al. Pre-synaptic BK channels 
selectively control glutamate versus 
GABA release from cortical and 
hippocampal nerve terminals. Journal of 
Neurochemistry. 2010;115(2):411-422. 
DOI: 10.1111/j.1471-4159.2010.06938.x
[47] Brenner R, Chen QH, Vilaythong A, 
et al. BK channel beta4 subunit reduces 
dentate gyrus excitability and protects 
against temporal lobe seizures. Nature 
Neuroscience. 2005;8(12):1752-1759. 
DOI: 10.1038/nn1573
[48] Shruti S, Clem RL, Barth AL. A 
seizure-induced gain-of-function in 
BK channels is associated with elevated 
firing activity in neocortical pyramidal 
neurons. Neurobiology of Disease. 
2008;30(3):323-330. DOI: 10.1016/j.
nbd.2008.02.002
[49] Sheehan JJ, Benedetti BL, Barth AL.  
Anticonvulsant effects of the 
BK-channel antagonist paxilline. 
Epilepsia. 2009;50(4):711-720. DOI: 
10.1111/j.1528-1167.2008.01888.x
[50] Tabarki B, AlMajhad N, 
AlHashem A, et al. Homozygous 
KCNMA1 mutation as a cause of 
cerebellar atrophy, developmental 
delay and seizures. Human Genetics. 
2016;135(11):1295-1298. DOI: 10.1007/
s00439-016-1726-y
[51] Riazi MA, Brinkman-Mills P, 
Johnson A, et al. Identification of 
a putative regulatory subunit of a 
calcium-activated potassium channel 
in the dup (3q) syndrome region and a 
related sequence on 22q11.2. Genomics. 
1999;62(1):90-94. DOI: 10.1006/
geno.1999.5975
[52] Lorenz S, Heils A, Kasper JM, 
et al. Allelic association of a truncation 
mutation of the KCNMB3 gene with 
idiopathic generalized epilepsy. 
American Journal of Medical Genetics. 
Part B, Neuropsychiatric Genetics. 
2007;144B(1):10-13. DOI: 10.1002/
ajmg.b.30369
[53] Uebele VN, Lagrutta A, Wade T, 
et al. Cloning and functional expression 
of two families of beta-subunits of the 
large conductance calcium-activated 
K+ channel. The Journal of Biological 
Chemistry. 2000;275(30):23211-23218. 
DOI: 10.1074/jbc.M910187199
[54] Zhu Y, Zhang S, Feng Y, et al. The 
yin and Yang of BK channels in epilepsy. 
CNS & Neurological Disorders Drug 
Targets. 2018. DOI: 10.2174/18715273176
66180213142403
[55] Abbott GW. KCNE1 and KCNE3: 
The yin and yang of voltage-gated K(+) 
channel regulation. Gene. 2016;576: 
(1 Pt 1):1-13. DOI: 10.1016/j.gene. 
2015.09.059
[56] Yang WP, Levesque PC, Little WA, 
et al. Functional expression of two 
KvLQT1-related potassium channels 
responsible for an inherited idiopathic 
epilepsy. The Journal of Biological 
Chemistry. 1998;273(31):19419-19423. 
DOI: 10.1074/jbc.273.31.19419
[57] Grigorov AO, Moskalyuk AA, 
Fedulova SA, et al. Differentiation 
of potassium currents in cultured 
inhibitory interneurons of the rat 
hippocampus (identification of 
the potassium M-type current). 
Neurophysiology. 2006;38(3): 
163-168
17
Ion Channels in Epilepsy: Blasting Fuse for Neuronal Hyperexcitability
DOI: http://dx.doi.org/10.5772/intechopen.83698
[58] Soldovieri MV, Boutry-Kryza N,  
Milh M, et al. Novel KCNQ2 and 
KCNQ3 mutations in a large cohort of 
families with benign neonatal epilepsy: 
First evidence for an altered channel 
regulation by syntaxin-1A. Human 
Mutation. 2014;35(3):356-367. DOI: 
10.1002/humu.22500
[59] Miceli F, Striano P, Soldovieri MV, 
et al. A novel KCNQ3 mutation in 
familial epilepsy with focal seizures 
and intellectual disability. Epilepsia. 
2015;56(2):e15-e20. DOI: 10.1111/
epi.12887
[60] Borgatti R, Zucca C, Cavallini A,  
et al. A novel mutation in KCNQ2 
associated with BFNC, drug resistant 
epilepsy, and mental retardation. 
Neurology. 2004;63(1):57-65. DOI: 
10.1212/01.WNL.0000132979.08394.6D
[61] Hibino H, Inanobe A, Furutani K, 
et al. Inwardly rectifying potassium 
channels: Their structure, function, 
and physiological roles. Physiological 
Reviews. 2010;90(1):291-366. DOI: 
10.1152/physrev.00021.2009
[62] Luscher C, Slesinger PA. Emerging 
roles for G protein-gated inwardly 
rectifying potassium (GIRK) channels 
in health and disease. Nature Reviews. 
Neuroscience. 2010;11(5):301-315. DOI: 
10.1038/nrn2834
[63] Koyrakh L, Lujan R, Colon J, et al. 
Molecular and cellular diversity of 
neuronal G-protein-gated potassium 
channels. The Journal of Neuroscience. 
2005;25(49):11468-11478. DOI: 10.1523/
jneurosci.3484-05.2005
[64] Mark MD, Herlitze S. G-protein 
mediated gating of inward-rectifier 
K+ channels. European Journal of 
Biochemistry. 2000;267(19):5830-5836. 
DOI: 10.1046/j.1432-1327.2000.01670.x
[65] Signorini S, Liao YJ, Duncan SA, 
et al. Normal cerebellar development 
but susceptibility to seizures in mice 
lacking G protein-coupled, inwardly 
rectifying K+ channel GIRK2. 
Proceedings of the National Academy 
of Sciences of the United States of 
America. 1997;94(3):923-927. DOI: 
10.1073/pnas.94.3.923
[66] Patil N, Cox DR, Bhat D, et al. A 
potassium channel mutation in weaver 
mice implicates membrane excitability 
in granule cell differentiation. Nature 
Genetics. 1995;11(2):126-129. DOI: 
10.1038/ng1095-126
[67] Slesinger PA, Patil N, Liao YJ, et al. 
Functional effects of the mouse weaver 
mutation on G protein-gated inwardly 
rectifying K+ channels. Neuron. 
1996;16(2):321-331. DOI: 10.1016/
S0896-6273(00)80050-1
[68] Pei Q , Lewis L, Grahame-Smith DG, 
et al. Alteration in expression of 
G-protein-activated inward rectifier 
K+−channel subunits GIRK1 and 
GIRK2 in the rat brain following 
electroconvulsive shock. Neuroscience. 
1999;90(2):621-627. DOI: 10.1016/
S0306-4522(98)00453-9
[69] Kaufmann K, Romaine I, Days E, 
et al. ML297 (VU0456810), the first 
potent and selective activator of the 
GIRK potassium channel, displays 
antiepileptic properties in mice. ACS 
Chemical Neuroscience. 2013;4(9): 
1278-1286. DOI: 10.1021/cn400062a
[70] Mazarati A, Lundstrom L, 
Sollenberg U, et al. Regulation 
of kindling epileptogenesis by 
hippocampal galanin type 1 and 
type 2 receptors: The effects of 
subtype-selective agonists and the 
role of G-protein-mediated signaling. 
The Journal of Pharmacology 
and Experimental Therapeutics. 
2006;318(2):700-708. DOI: 10.1124/
jpet.106.104703
[71] Catterall WA. Voltage-gated 
calcium channels. Cold Spring 
Harbor Perspectives in Biology. 
Epilepsy - Advances in Diagnosis and Therapy
18
2011;3(8):a003947. DOI: 10.1101/
cshperspect.a003947
[72] Fatt P, Katz B. The electrical 
properties of crustacean muscle fibres. 
The Journal of Physiology. 1953;120 
(1-2):171-204. DOI: 10.1113/
jphysiol.1953.sp004884
[73] Borsotto M, Barhanin J, Fosset M, 
et al. The 1,4-dihydropyridine receptor 
associated with the skeletal muscle 
voltage-dependent Ca2+ channel. 
Purification and subunit composition. 
The Journal of Biological Chemistry. 
1985;260(26):14255-14263
[74] Takahashi M, Seagar MJ, Jones JF,  
et al. Subunit structure of 
dihydropyridine-sensitive calcium 
channels from skeletal muscle. 
Proceedings of the National Academy 
of Sciences of the United States of 
America. 1987;84(15):5478-5482. DOI: 
10.1073/pnas.84.15.5478
[75] Furukawa T. Types of voltage-
gated calcium channels: Molecular and 
electrophysiological views. Current 
Hypertension Reviews. 2013;9(3): 
170-181. DOI: 10.2174/157340211066614
0131155912
[76] Ma H, Cohen S, Li B, et al. 
Exploring the dominant role of Cav1 
channels in signalling to the nucleus. 
Bioscience Reports. 2012;33(1):97-101. 
DOI: 10.1042/bsr20120099
[77] Radzicki D, Yau HJ, Pollema-Mays 
SL, et al. Temperature-sensitive Cav1.2 
calcium channels support intrinsic 
firing of pyramidal neurons and provide 
a target for the treatment of febrile 
seizures. The Journal of Neuroscience. 
2013;33(24):9920-9931. DOI: 10.1523/
jneurosci.5482-12.2013
[78] Durmus N, Kaya T, Gulturk S, 
et al. The effects of L type calcium 
channels on the electroencephalogram 
recordings in WAG/RIJ rat model of 
absence epilepsy. European Review for 
Medical and Pharmacological Sciences. 
2013;17(9):1149-1154
[79] Han DY, Guan BJ, Wang YJ, et al. 
L-type calcium channel blockers 
enhance trafficking and function of 
epilepsy-associated alpha1(D219N) 
subunits of GABA(a) receptors. ACS 
Chemical Biology. 2015;10(9):2135-2148. 
DOI: 10.1021/acschembio.5b00479
[80] Qian J, Noebels JL. Presynaptic Ca2+ 
channels and neurotransmitter release 
at the terminal of a mouse cortical 
neuron. The Journal of Neuroscience. 
2001;21(11):3721-3728. DOI: 10.1523/
JNEUROSCI.21-11-03721.2001
[81] Bomben VC, Aiba I, Qian J, et al. 
Isolated P/Q calcium channel deletion 
in layer VI corticothalamic neurons 
generates absence epilepsy. The Journal 
of Neuroscience. 2016;36(2):405-418. 
DOI: 10.1523/jneurosci.2555-15.2016
[82] Rossignol E, Kruglikov I, van 
den Maagdenberg AM, et al. CaV 
2.1 ablation in cortical interneurons 
selectively impairs fast-spiking basket 
cells and causes generalized seizures. 
Annals of Neurology. 2013;74(2): 
209-222. DOI: 10.1002/ana.23913
[83] Maejima T, Wollenweber P, 
Teusner LU, et al. Postnatal loss 
of P/Q-type channels confined to 
rhombic-lip-derived neurons alters 
synaptic transmission at the parallel 
fiber to purkinje cell synapse and 
replicates genomic Cacna1a mutation 
phenotype of ataxia and seizures in 
mice. The Journal of Neuroscience. 
2013;33(12):5162-5174. DOI: 10.1523/
jneurosci.5442-12.2013
[84] Letts VA, Mahaffey CL, Beyer B, 
et al. A targeted mutation in Cacng4 
exacerbates spike-wave seizures in 
stargazer (Cacng2) mice. Proceedings 
of the National Academy of Sciences 
of the United States of America. 
2005;102(6):2123-2128. DOI: 10.1073/
pnas.0409527102
19
Ion Channels in Epilepsy: Blasting Fuse for Neuronal Hyperexcitability
DOI: http://dx.doi.org/10.5772/intechopen.83698
[85] Barclay J, Balaguero N, Mione M,  
et al. Ducky mouse phenotype of 
epilepsy and ataxia is associated 
with mutations in the Cacna2d2 
gene and decreased calcium channel 
current in cerebellar Purkinje 
cells. The Journal of Neuroscience. 
2001;21(16):6095-6104. DOI: 10.1523/
JNEUROSCI.21-16-06095.2001
[86] Xu JH, Long L, Wang J, et al. 
Nuclear localization of Ca(v)2.2 and 
its distribution in the mouse central 
nervous system, and changes in 
the hippocampus during and after 
pilocarpine-induced status epilepticus. 
Neuropathology and Applied 
Neurobiology. 2010;36(1):71-85. DOI: 
10.1111/j.1365-2990.2009.01044.x
[87] Weiergraber M, Henry M, Ho 
MS, et al. Altered thalamocortical 
rhythmicity in Ca(v)2.3-deficient mice. 
Molecular and Cellular Neurosciences. 
2008;39(4):605-618. DOI: 10.1016/j.
mcn.2008.08.007
[88] Zaman T, Lee K, Park C, et al. 
Cav2.3 channels are critical for 
oscillatory burst discharges in the 
reticular thalamus and absence epilepsy. 
Neuron. 2011;70(1):95-108. DOI: 
10.1016/j.neuron.2011.02.042
[89] Weiergraber M, Henry M, 
Radhakrishnan K, et al. Hippocampal 
seizure resistance and reduced neuronal 
excitotoxicity in mice lacking the 
Cav2.3 E/R-type voltage-gated calcium 
channel. Journal of Neurophysiology. 
2007;97(5):3660-3669. DOI: 10.1152/
jn.01193.2006
[90] Catterall WA. Structure and 
regulation of voltage-gated Ca2+ 
channels. Annual Review of Cell 
and Developmental Biology. 
2000;16:521-555. DOI: 10.1146/annurev.
cellbio.16.1.521
[91] Catterall WA, Perez-Reyes E, 
Snutch TP, et al. International Union of 
Pharmacology. XLVIII. Nomenclature 
and structure-function relationships 
of voltage-gated calcium channels. 
Pharmacological Reviews. 
2005;57(4):411-425. DOI: 10.1124/
pr.57.4.5
[92] Shin HS, Cheong EJ, Choi S, et al. 
T-type Ca2+ channels as therapeutic 
targets in the nervous system. Current 
Opinion in Pharmacology. 2008;8(1): 
33-41. DOI: 10.1016/j.coph.2007.12.003
[93] Huguenard JR. Neuronal circuitry 
of thalamocortical epilepsy and 
mechanisms of antiabsence drug 
action. Advances in Neurology. 
1999;79:991-999
[94] Talley EM, Solorzano G, Depaulis 
A, et al. Low-voltage-activated calcium 
channel subunit expression in a genetic 
model of absence epilepsy in the 
rat. Brain Research. Molecular Brain 
Research. 2000;75(1):159-165. DOI: 
10.1016/S0169-328X(99)00307-1
[95] Rimoli MG, Russo E, Cataldi 
M, et al. T-type channel blocking 
properties and antiabsence activity 
of two imidazo[1,2-b]pyridazine 
derivatives structurally related to 
indomethacin. Neuropharmacology. 
2009;56(3):637-646. DOI: 10.1016/j.
neuropharm.2008.11.003
[96] Sharop BR, Boldyriev OI, Batiuk 
MY, et al. Compensatory reduction of 
Cav3.1 expression in thalamocortical 
neurons of juvenile rats of WAG/Rij 
model of absence epilepsy. Epilepsy 
Research. 2016;119:10-12. DOI: 
10.1016/j.eplepsyres.2015.11.008
[97] Kim D, Song I, Keum S, et al. Lack 
of the burst firing of thalamocortical 
relay neurons and resistance to absence 
seizures in mice lacking alpha(1G) 
T-type Ca(2+) channels. Neuron. 
2001;31(1):35-45. DOI: 10.1016/
S0896-6273(01)00343-9
[98] Khosravani H, Bladen C, Parker DB, 
et al. Effects of Cav3.2 channel 
Epilepsy - Advances in Diagnosis and Therapy
20
mutations linked to idiopathic 
generalized epilepsy. Annals of 
Neurology. 2005;57(5):745-749. DOI: 
10.1002/ana.20458
[99] Chen Y, Lu J, Pan H, et al. 
Association between genetic variation 
of CACNA1H and childhood absence 
epilepsy. Annals of Neurology. 
2003;54(2):239-243. DOI: 10.1002/
ana.10607
[100] Eckle VS, Shcheglovitov A, Vitko I, 
et al. Mechanisms by which a CACNA1H 
mutation in epilepsy patients increases 
seizure susceptibility. The Journal of 
Physiology. 2014;592(4):795-809. DOI: 
10.1113/jphysiol.2013.264176
[101] Venkatachalam K, Montell C.  
TRP channels. Annual Review of 
Biochemistry. 2007;76:387-417.  
DOI: 10.1146/annurev.
biochem.75.103004.142819
[102] Phelan KD, Shwe UT, Abramowitz 
J, et al. Canonical transient 
receptor channel 5 (TRPC5) and 
TRPC1/4 contribute to seizure and 
excitotoxicity by distinct cellular 
mechanisms. Molecular Pharmacology. 
2013;83(2):429-438. DOI: 10.1124/
mol.112.082271
[103] Phelan KD, Shwe UT, Cozart MA, 
et al. TRPC3 channels play a critical role 
in the theta component of pilocarpine-
induced status epilepticus in mice. 
Epilepsia. 2017;58(2):247-254. DOI: 
10.1111/epi.13648
[104] Nagamine K, Kudoh J, Minoshima 
S, et al. Molecular cloning of a novel 
putative Ca2+ channel protein (TRPC7) 
highly expressed in brain. Genomics. 
1998;54(1):124-131. DOI: 10.1006/
geno.1998.5551
[105] Bhaskaran MD, Smith BN. Effects 
of TRPV1 activation on synaptic 
excitation in the dentate gyrus of 
a mouse model of temporal lobe 
epilepsy. Experimental Neurology. 
2010;223(2):529-536. DOI: 10.1016/j.
expneurol.2010.01.021
[106] Iannotti FA, Hill CL, Leo A,  
et al. Nonpsychotropic plant 
cannabinoids, cannabidivarin (CBDV) 
and cannabidiol (CBD), activate and 
desensitize transient receptor potential 
vanilloid 1 (TRPV1) channels in vitro: 
Potential for the treatment of neuronal 
hyperexcitability. ACS Chemical 
Neuroscience. 2014;5(11):1131-1141. 
DOI: 10.1021/cn5000524
[107] Fawley JA, Hofmann ME, 
Andresen MC. Cannabinoid 1 and 
transient receptor potential vanilloid 1 
receptors discretely modulate evoked 
glutamate separately from spontaneous 
glutamate transmission. The Journal of 
Neuroscience. 2014;34(24):8324-8332. 
DOI: 10.1523/JNEUROSCI.0315-14.2014
[108] Naziroglu M, Ovey IS. Involvement 
of apoptosis and calcium accumulation 
through TRPV1 channels in 
neurobiology of epilepsy. Neuroscience. 
2015;293:55-66. DOI: 10.1016/j.
neuroscience.2015.02.041
[109] Ghazizadeh V, Naziroglu M.  
Electromagnetic radiation (Wi-fi) 
and epilepsy induce calcium entry and 
apoptosis through activation of TRPV1 
channel in hippocampus and dorsal 
root ganglion of rats. Metabolic Brain 
Disease. 2014;29(3):787-799. DOI: 
10.1007/s11011-014-9549-9
[110] Naziroglu M, Ozkan FF, Hapil SR, 
et al. Epilepsy but not mobile phone 
frequency (900 MHz) induces apoptosis 
and calcium entry in hippocampus of 
epileptic rat: Involvement of TRPV1 
channels. The Journal of Membrane 
Biology. 2015;248(1):83-91. DOI: 
10.1007/s00232-014-9744-y
[111] Edwards JG, Gibson HE, Jensen T,  
et al. A novel non-CB1/TRPV1 
endocannabinoid-mediated mechanism 
depresses excitatory synapses on 
hippocampal CA1 interneurons. 
21
Ion Channels in Epilepsy: Blasting Fuse for Neuronal Hyperexcitability
DOI: http://dx.doi.org/10.5772/intechopen.83698
Hippocampus. 2012;22(2):209-221. 
DOI: 10.1002/hipo.20884
[112] Barker BS, Ottolini M, Wagnon JL,  
et al. The SCN8A encephalopathy 
mutation p.Ile1327Val displays elevated 
sensitivity to the anticonvulsant 
phenytoin. Epilepsia. 2016;57(9): 
1458-1466. DOI: 10.1111/epi.13461
[113] Liu J, Gao C, Chen W, et al. 
CRISPR/Cas9 facilitates investigation 
of neural circuit disease using human 
iPSCs: Mechanism of epilepsy caused by 
an SCN1A loss-of-function mutation. 
Translational Psychiatry. 2016;6:e703. 
DOI: 10.1038/tp.2015.203
[114] Jiang Q , Li K, Lu WJ, et al. 
Identification of small-molecule ion 
channel modulators in C. elegans 
channelopathy models. Nature 
Communications. 2018;9(1):3941. DOI: 
10.1038/s41467-018-06514-5
[115] Sourbron J, Smolders I, de Witte P,  
et al. Pharmacological analysis of 
the anti-epileptic mechanisms of 
fenfluramine in scn1a mutant zebrafish. 
Frontiers in Pharmacology. 2017;8:191. 
DOI: 10.3389/fphar.2017.00191
[116] Ye J, Tang S, Meng L, et al. 
Ultrasonic control of neural 
activity through activation of the 
mechanosensitive channel MscL. Nano 
Letters. 2018;18(7):4148-4155. DOI: 
10.1021/acs.nanolett.8b00935
[117] Tonnesen J, Kokaia M. Epilepsy and 
optogenetics: Can seizures be controlled 
by light? Clinical Science (London, 
England). 2017;131(14):1605-1616. DOI: 
10.1042/CS20160492
